T0	Participants 45 85	children with autism spectrum disorders:
T1	Participants 210 265	children with autism spectrum disorders ages 3-8 years.
T2	Participants 274 343	Phase 1 involved 65 children who received one round of DMSA (3 days).
T3	Participants 344 403	Participants who had high urinary excretion of toxic metals
T4	Participants 448 472	phase 2, 49 participants